4//SEC Filing
Sinha Uma 4
Accession 0000899243-20-032771
CIK 0001731831other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:34 PM ET
Size
10.4 KB
Accession
0000899243-20-032771
Insider Transaction Report
Form 4
Sinha Uma
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-12-02$90.63/sh−702$63,625→ 317,025 total - Sale
Common Stock
2020-12-02$89.63/sh−3,798$340,402→ 317,727 total - Sale
Common Stock
2020-12-02$92.97/sh−200$18,593→ 316,525 total - Sale
Common Stock
2020-12-02$91.89/sh−300$27,567→ 316,725 total
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 13, 2020.
- [F2]Represents the weighted average sale price of the shares sold ranging from $89.15 to $90.125 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5.
- [F3]Represents the weighted average sale price of the shares sold ranging from $90.33 to $91.18 per share.
- [F4]Represents the weighted average sale price of the shares sold ranging from $91.56 to $92.10 per share.
- [F5]Represents the weighted average sale price of the shares sold ranging from $92.71 to $93.22 per share.
Documents
Issuer
Eidos Therapeutics, Inc.
CIK 0001731831
Entity typeother
Related Parties
1- filerCIK 0001742587
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:34 PM ET
- Size
- 10.4 KB